Human coronavirus 229E 3CL protease (HCoV-229E 3CLpro)

The Human coronavirus 229E 3CL protease, also known as the main protease (Mpro) or nsp5, is a critical enzyme in the life cycle of HCoV-229E, an alphacoronavirus that causes the common cold and occasionally severe respiratory diseases like pneumonia [1, 5, 11]. It functions as a homodimer and is responsible for the proteolytic processing of the large viral polyproteins, pp1a and pp1ab, at 11 conserved sites to release functional non-structural proteins essential for viral replication and transcription [12, 13, 16]. The enzyme's catalytic mechanism involves a Cys144-His41 dyad, and its high degree of conservation across coronaviruses makes it a prime target for broad-spectrum antiviral development [1, 6, 17]. Because no human proteases share its specific cleavage requirements, inhibitors targeting this enzyme typically exhibit high selectivity and low host toxicity [1, 2]. Several potent inhibitors, including nirmatrelvir and experimental compounds like GC376 and MK-7845, have been shown to effectively block its activity, thereby inhibiting viral replication [1, 4, 12].

Other names

HCoV-229E MproHuman coronavirus 229E main protease3C-like proteinasensp5Non-structural protein 5

The 3CL protease inhibitors bind to the active site of the enzyme, often forming a covalent bond with the catalytic cysteine residue (Cys144 in HCoV-229E), which prevents the protease from cleaving the viral polyproteins pp1a and pp1ab into functional non-structural proteins, thereby arresting viral replication [1, 13, 17].